These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29476883)

  • 1. Active surveillance for carbapenem-resistant Enterobacteriaceae, vancomycin-resistant enterococci and toxigenic Clostridium difficile among patients transferred from long-term care facilities in Korea.
    Hwang JH; Park JS; Lee E; Bae JY; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Park SW; Kim NJ; Oh M; Kim HB
    J Hosp Infect; 2018 Aug; 99(4):487-491. PubMed ID: 29476883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-prevalence survey of carbapenemase-producing Enterobacteriaceae and vancomycin-resistant enterococci in adult inpatients in a university teaching hospital in the UK.
    Wilson HJ; Khokhar F; Enoch DA; Brown NM; Ahluwalia J; Dougan G; Török ME
    J Hosp Infect; 2018 Sep; 100(1):35-39. PubMed ID: 29969691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study.
    Dinh A; Fessi H; Duran C; Batista R; Michelon H; Bouchand F; Lepeule R; Vittecoq D; Escaut L; Sobhani I; Lawrence C; Chast F; Ronco P; Davido B
    J Hosp Infect; 2018 Aug; 99(4):481-486. PubMed ID: 29477634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic rectal colonization with carbapenem-resistant Enterobacteriaceae and Clostridium difficile among residents of a long-term care facility in New York City.
    Prasad N; Labaze G; Kopacz J; Chwa S; Platis D; Pan CX; Russo D; LaBombardi VJ; Osorio G; Pollack S; Kreiswirth BN; Chen L; Urban C; Segal-Maurer S
    Am J Infect Control; 2016 May; 44(5):525-32. PubMed ID: 26796684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can real-time polymerase chain reaction allow a faster recovery of hospital activity in cases of an incidental discovery of carbapenemase-producing Enterobacteriaceae and vancomycin-resistant Enterococci carriers?
    Saliba R; Neulier C; Seytre D; Fiacre A; Faibis F; Leduc P; Amara M; Jauréguy F; Carbonnelle E; Zahar JR; Marty L
    J Hosp Infect; 2019 Oct; 103(2):115-120. PubMed ID: 31279758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonisation with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and meticillin-resistant Staphylococcus aureus in a long-term care facility over one year.
    Ludden C; Cormican M; Vellinga A; Johnson JR; Austin B; Morris D
    BMC Infect Dis; 2015 Apr; 15():168. PubMed ID: 25887288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of multidrug resistant Enterobacteriaceae among residents of long term care facilities in Amsterdam, the Netherlands.
    van Dulm E; Tholen ATR; Pettersson A; van Rooijen MS; Willemsen I; Molenaar P; Damen M; Gruteke P; Oostvogel P; Kuijper EJ; Hertogh CMPM; Vandenbroucke-Grauls CMJE; Scholing M
    PLoS One; 2019; 14(9):e0222200. PubMed ID: 31513682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germs of thrones - spontaneous decolonization of Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococci (VRE) in Western Europe: is this myth or reality?
    Davido B; Moussiegt A; Dinh A; Bouchand F; Matt M; Senard O; Deconinck L; Espinasse F; Lawrence C; Fortineau N; Saleh-Mghir A; Caballero S; Escaut L; Salomon J
    Antimicrob Resist Infect Control; 2018; 7():100. PubMed ID: 30123500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin-resistant Enterococcus co-colonization rates with methicillin-resistant Staphylococcus aureus and Clostridium difficile in critically ill veterans.
    McKinley L; Becerra B; Moriarty H; Short TH; Hagle M; Reymann A; Valentine S; Duster M; Warrack S; Safdar N
    Am J Infect Control; 2016 Sep; 44(9):1047-9. PubMed ID: 27067517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing.
    Özsoy S; İlki A
    Braz J Microbiol; 2017; 48(3):489-492. PubMed ID: 28389190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug-resistant infections in long-term care facilities: extended-spectrum β-lactamase-producing Enterobacteriaceae and hypervirulent antibiotic resistant Clostridium difficile.
    Giufrè M; Accogli M; Ricchizzi E; Barbanti F; Farina C; Fazii P; Mattei R; Sarti M; Barozzi A; Buttazzi R; Cosentino M; Nardone M; Savini V; Spigaglia P; Moro ML; Cerquetti M
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):275-281. PubMed ID: 29571838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymptomatic carriage of extensively drug-resistant bacteria (eXDR), a simple way to assess spontaneous clearance.
    Farfour E; Si Larbi AG; Couturier J; Lecuru M; Decousser JW; Renvoise A; Faibis F; Lawrence C; Nerome S; Lecointe D;
    J Hosp Infect; 2020 Apr; 104(4):503-507. PubMed ID: 31874205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections.
    Bartoletti M; Tedeschi S; Pascale R; Raumer L; Maraolo AE; Palmiero G; Tumietto F; Cristini F; Ambretti S; Giannella M; Lewis RE; Viale P
    Int J Antimicrob Agents; 2018 Mar; 51(3):516-521. PubMed ID: 29410250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yield of vancomycin-resistant enterococci and multidrug-resistant Enterobacteriaceae from stools submitted for Clostridium difficile testing compared to results from a focused surveillance program.
    Hacek DM; Bednarz P; Noskin GA; Zembower T; Peterson LR
    J Clin Microbiol; 2001 Mar; 39(3):1152-4. PubMed ID: 11230446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria carriage?
    Davido B; Batista R; Michelon H; Lepainteur M; Bouchand F; Lepeule R; Salomon J; Vittecoq D; Duran C; Escaut L; Sobhani I; Paul M; Lawrence C; Perronne C; Chast F; Dinh A
    J Hosp Infect; 2017 Apr; 95(4):433-437. PubMed ID: 28237504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of Clostridioides difficile and multidrug-resistant healthcare-associated pathogens in stool specimens from hospitalized patients in the USA.
    Tickler IA; Dela Cruz CM; Obradovich AE; Goering RV; Dewell S; Le VM; Tenover FC;
    J Hosp Infect; 2020 Sep; 106(1):179-185. PubMed ID: 32649974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors for colonization by Clostridium difficile and extended-spectrum β-lactamase-producing Enterobacteriaceae in rehabilitation clinics in Germany.
    Arvand M; Ruscher C; Bettge-Weller G; Goltz M; Pfeifer Y
    J Hosp Infect; 2018 Jan; 98(1):14-20. PubMed ID: 28705583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of vancomycin-resistant enterococci colonization in critically ill pediatric patients.
    Sutcu M; Akturk H; Acar M; Salman N; Aydın D; Akgun Karapınar B; Ozdemir A; Cihan R; Citak A; Somer A
    Am J Infect Control; 2016 May; 44(5):515-9. PubMed ID: 26781220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications for vancomycin-resistant Enterococcus colonization associated with Clostridium difficile infections.
    Fujitani S; George WL; Morgan MA; Nichols S; Murthy AR
    Am J Infect Control; 2011 Apr; 39(3):188-93. PubMed ID: 21458682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin-resistant enterococci carriage in an acute Irish hospital.
    Whelton E; Lynch C; O'Reilly B; Corcoran GD; Cryan B; Keane SM; Sleator RD; Lucey B
    J Hosp Infect; 2016 Jun; 93(2):175-80. PubMed ID: 27112046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.